{"id":169,"date":"2014-12-31T03:44:02","date_gmt":"2014-12-31T03:44:02","guid":{"rendered":"http:\/\/labs.icahn.mssm.edu\/cholab\/?page_id=169"},"modified":"2023-11-17T17:15:18","modified_gmt":"2023-11-17T17:15:18","slug":"ibd-genetics-consortium","status":"publish","type":"page","link":"https:\/\/labs.icahn.mssm.edu\/cholab\/ibd-genetics-consortium\/","title":{"rendered":"IBD Genetics Consortium"},"content":{"rendered":"<p style=\"text-align: center\">The\u00a0<a href=\"https:\/\/www.ibdgc.org\/home\">NIDDK Inflammatory Bowel Disease Genetics Consortium<\/a>\u00a0(IBDGC) was created to advance genetic research on Crohn\u2019s Disease and Ulcerative Colitis. The overall objective of the Consortium is the identification of genes or genomic regions that are associated with increased risk of IBD and with specific phenotypic manifestations. The IBDGC has two primary responsibilities:<\/p>\n<p style=\"text-align: center\"><strong><em><span style=\"color: #000000\">Manage a repository of Crohn\u2019s disease and ulcerative colitis biospecimen for use by the Consortium members and the external scientific community.<\/span><\/em><\/strong><\/p>\n<p style=\"text-align: center\"><strong><em><span style=\"color: #000000\"><span style=\"color: #000000\">Conduct genetic analyses to identify genes and loci associated with Inflammatory Bowel Disease.<\/span><\/span><\/em><\/strong><\/p>\n<hr \/>\n<p><span style=\"color: #000000\">The Data Coordinator Center (DCC), led by the Icahn School of Medicine at Mount Sinai and the University of Chicago, manages the IBDGC:<\/span><\/p>\n<ul>\n<li><span style=\"color: #000000\">Judy H. Cho, MD, Principal Investigator<\/span><\/li>\n<li><span style=\"color: #000000\">Ronald A. Thisted, PhD, PhD, Scientific Director of DCC operations, University of Chicago<\/span><\/li>\n<li><span style=\"color: #000000\">Yashoda Sharma, PhD, Project Administrator<\/span><\/li>\n<li><span style=\"color: #000000\">Phil Schumm, MA, Technical Director of DCC operations, University of Chicago<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000\">\u00a0<\/span><\/p>\n<hr \/>\n<p><span style=\"color: #000000\">In addition, the IBDGC consists of six genetic research centers (GRC):<\/span><\/p>\n<ul>\n<li><span style=\"color: #000000\">Icahn School of Medicine at Mount Sinai &#8211; Judy H. Cho, MD<\/span><\/li>\n<li><span style=\"color: #000000\">Cedars Sinai Medical Center \u2013 Dermot B. P. McGovern, MD, PhD, MRCP<\/span><\/li>\n<li><span style=\"color: #000000\">Johns Hopkins University &#8211; Steven R. Brant, MD<\/span><\/li>\n<li><span style=\"color: #000000\">University of Montreal &#8211; John D. Rioux, PhD<\/span><\/li>\n<li><span style=\"color: #000000\">University of Pittsburgh &#8211; Richard H. Duerr, MD<\/span><\/li>\n<li><span style=\"color: #000000\">University of Toronto &#8211; Mark Silverberg, MD, PhD, FRCPC<\/span><\/li>\n<\/ul>\n<p><span style=\"color: #000000\">\u00a0<\/span><\/p>\n<hr \/>\n<p style=\"text-align: center\"><span style=\"color: #000000\">The DCC facilitates scientific interaction between individual GRCs through the collection, organization and analysis of study data, especially with the use of common data structures, existing and novel analytic approaches, and testing of interrelated hypotheses.<\/span><\/p>\n<p style=\"text-align: center\"><span style=\"color: #000000\">We are involved with independent genetic research studies and actively work with members of the IBD and genetic communities on collaborative projects. Our studies utilize DNA and other biospecimens from patients affected with Inflammatory Bowel Disease and healthy controls. Genetic information is analyzed as we strive to identify and better understand the way in which IBD manifests and how certain genetic traits contribute to this manifestation. Together, we have implicated 163 genetic loci with IBD susceptibility.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The\u00a0NIDDK Inflammatory Bowel Disease Genetics Consortium\u00a0(IBDGC) was created to advance genetic research on Crohn\u2019s Disease and Ulcerative Colitis. The overall objective of the Consortium is the identification of genes or genomic regions that are associated with increased risk of IBD and with specific phenotypic manifestations. The IBDGC has two primary responsibilities: Manage a repository of [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":6,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"class_list":["post-169","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/pages\/169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/comments?post=169"}],"version-history":[{"count":3,"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/pages\/169\/revisions"}],"predecessor-version":[{"id":1438,"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/pages\/169\/revisions\/1438"}],"wp:attachment":[{"href":"https:\/\/labs.icahn.mssm.edu\/cholab\/wp-json\/wp\/v2\/media?parent=169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}